A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill mifepristone nationwide.

The Texas Attorney General is following his familiar playbook by taking the case to a federal judge with a record of rulings against the Biden administration’s agenda.

The U.S. Supreme Court has ruled unanimously to preserve access to mifepristone, the drug most commonly used in medication abortions.

A majority of Supreme Court justices seemed open to keeping mifepristone, a common abortion-inducing drug, on the market despite a Texas ruling revoking its FDA approval.

The Supreme Court has rejected an emergency appeal from a student group that has been blocked from staging a drag show at a public university in Texas.

A three-judge panel in New Orleans ruled that a Texas law requiring minors to obtain parental consent to obtain birth control does not conflict with the goals of the federally-funded Title X program, which has given teens birth control confidentially.

U.S. District Judge Matthew Kacsmaryk ruled that the student fundraiser featuring drag performers was not protected, raising the stakes for a battle over First Amendment rights and drag shows.

Planned Parenthood has managed to stay open in Texas despite the state’s best efforts to shut it down. But a lawsuit in front of a conservative judge poses an existential threat.

Lawyers seeking to preserve pregnant women’s access to a drug used in the most common method of abortion got pushback Wednesday from appellate judges with a history of supporting abortion restrictions.

Nothing will change for now.

Nothing will change for now.

The legal challenge to mifepristone now returns to the 5th Circuit Court of Appeals in New Orleans.

The U.S. Supreme Court originally planned to weigh in on the abortion pill case by Wednesday night, but extended the hold on the Amarillo ruling until Friday at midnight.

The Supreme Court is temporarily keeping in place federal rules for use of an abortion drug, while it takes time to more fully consider the issues raised in a court challenge.

The Supreme Court will be the next stop for a legal fight over the pill used in the nation’s most common abortion method.

A handful of states led by Democratic governors are stockpiling doses of drugs used in medication abortions amid fears that a court ruling could restrict access to the most commonly used method of abortion in the U.S. Massachusetts has purchased enough doses of the drug mifepristone to last for more than a year.

The Justice Department is appealing a Texas court ruling that would halt approval of a drug used in the most common method of abortion in the U_S_ In its appeal Monday, the Justice Department called the decision “extraordinary and unprecedented.”.

The Department of Justice on Monday filed a request in federal court seeking to block a ruling last week by a Trump-appointed judge that endangers access to the key abortion pill mifepristone.

Competing rulings by two federal judges over the availability of the abortion pill mifepristone are sowing alarm and confusion — and opening a new front in the battle over abortion in the United States.

An anti-abortion organization has planned a protest in front of a Montrose-area Walgreens on Saturday following a federal judge’s decision to put a hold on the federal approval of mifepristone overnight Friday.

A Texas judge who sparked a legal firestorm with an unprecedented ruling halting approval of the nation’s most common method of abortion is a former attorney for a religious liberty legal group with a long history pushing conservative causes.

The ruling from U.S. District Judge Matthew Kacsmaryk in Amarillo could potentially upend access to medication abortion nationwide.

Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years.

The lawsuit comes after protests each day this week, calling for university president Walter Wendler to reinstate the drag show and step down.

Anti-abortion advocates are trying to revive the long-dormant 1873 Comstock Act, which banned mailing of anything related to abortion or contraception, in a lawsuit about mifepristone, an abortion-inducing drug.

A federal judge has heard arguments in a lawsuit that poses a threat to the nationwide availability of a leading abortion medication.

A Texas judge hearing a case that could throw into jeopardy access to the nation’s most common method of abortion is a former attorney for a Christian legal group who critics say is being sought out by conservative litigants because they believe he’ll be sympathetic to their causes.

U.S. District Matthew Kacsmaryk was once deputy counsel for the the First Liberty Institute, the Plano-based conservative Christian law firm.

A conservative judge in Texas has raised questions about an effort to overturn the decades-old approval of a leading abortion drug, in a case that could threaten the country’s most common method to end pregnancies.

A federal judge overseeing a high-stakes case that could threaten access to medication abortion across the nation asked lawyers for the “courtesy” of not publicizing upcoming arguments.

A Texas lawsuit is posing a threat to the nationwide availability of medication abortion, which now accounts for the majority of abortions in the U.S. The case filed by abortion opponents who helped challenge Roe v. Wade seeks to reverse a decades-old approval by the Food and Drug Administration.

The Title X program has long provided free, confidential contraception to anyone, regardless of age, income or immigration status. A North Texas federal judge ruled in December that the program violates Texas law and parents’ rights.

U.S. District Judge Matthew Kacsmaryk, a former religious liberty lawyer, found that a federal program that gives teens access to birth control denies a parent “a fundamental right to control and direct the upbringing of his minor children.”

The Biden administration stopped enrolling new asylum seekers into the Trump-era program in August.

The “remain in Mexico” policy known as Migrant Protection Protocols requires many asylum-seekers to wait outside the United States for their cases to be decided.